BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21444595)

  • 1. State laws regarding the retention and use of residual newborn screening blood samples.
    Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J
    Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public attitudes regarding the use of residual newborn screening specimens for research.
    Botkin JR; Rothwell E; Anderson R; Stark L; Goldenberg A; Lewis M; Burbank M; Wong B
    Pediatrics; 2012 Feb; 129(2):231-8. PubMed ID: 22250018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of neonatal dried blood spot retrieval amid evolving state policies (2009-2010): a Children's Oncology Group study.
    Linabery AM; Slater ME; Spector LG; Olshan AF; Stork SK; Roesler MA; Reaman GH; Ross JA
    Paediatr Perinat Epidemiol; 2011 Nov; 25(6):549-58. PubMed ID: 21980944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the residual newborn screening dried blood sample litigation.
    Lewis MH
    J Law Med Ethics; 2015; 43 Suppl 1():32-5. PubMed ID: 25846160
    [No Abstract]   [Full Text] [Related]  

  • 5. Storage and use of residual dried blood spots.
    Webster D; ;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():49-51. PubMed ID: 15906694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn dried blood spot screening: residual specimen storage issues.
    Therrell BL; Hannon WH
    Pediatrics; 2012 Feb; 129(2):365-6. PubMed ID: 22250020
    [No Abstract]   [Full Text] [Related]  

  • 7. Storage and use of residual dried blood spots from state newborn screening programs.
    Olney RS; Moore CA; Ojodu JA; Lindegren ML; Hannon WH
    J Pediatr; 2006 May; 148(5):618-22. PubMed ID: 16737872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MN Supreme Court rules on newborn screening samples.
    Minn Med; 2011 Dec; 94(12):18-9. PubMed ID: 22372040
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative analysis of the governance and use of residual dried blood spots from state newborn screening programs and neonatal biobanks.
    Preslan ED; Mathews DJ
    J Empir Res Hum Res Ethics; 2013 Jul; 8(3):22-33. PubMed ID: 23933773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What parents want to know about the storage and use of residual newborn bloodspots.
    Botkin JR; Rothwell E; Anderson RA; Goldenberg A; Kuppermann M; Dolan SM; Rose NC; Stark L
    Am J Med Genet A; 2014 Nov; 164A(11):2739-44. PubMed ID: 25131714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual newborn screening samples for research: parental information needs for decision-making.
    Rothwell E; Clark L; Anderson R; Botkin JR
    J Spec Pediatr Nurs; 2013 Apr; 18(2):115-22. PubMed ID: 23560583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of newborn screening programs in the United States.
    Therrell BL; Johnson A; Williams D
    Pediatrics; 2006 May; 117(5 Pt 2):S212-52. PubMed ID: 16735250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention and research use of residual newborn screening bloodspots.
    Botkin JR; Goldenberg AJ; Rothwell E; Anderson RA; Lewis MH
    Pediatrics; 2013 Jan; 131(1):120-7. PubMed ID: 23209103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common criteria among States for storage and use of dried blood spot specimens after newborn screening.
    Petrini C; Olivieri A; Corbetta C; Cerone R; D'Agnolo G; Bompiani A
    Ann Ist Super Sanita; 2012; 48(2):119-21. PubMed ID: 22751553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public participation in medical policy-making and the status of consumer autonomy: the example of newborn-screening programs in the United States.
    Hiller EH; Landenburger G; Natowicz MR
    Am J Public Health; 1997 Aug; 87(8):1280-8. PubMed ID: 9279262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citizens' values regarding research with stored samples from newborn screening in Canada.
    Bombard Y; Miller FA; Hayeems RZ; Carroll JC; Avard D; Wilson BJ; Little J; Bytautas JP; Allanson J; Axler R; Giguere Y; Chakraborty P
    Pediatrics; 2012 Feb; 129(2):239-47. PubMed ID: 22250019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research results: preserving newborn blood samples.
    Lewis MH; Scheurer ME; Green RC; McGuire AL
    Sci Transl Med; 2012 Nov; 4(159):159cm12. PubMed ID: 23136040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal Education of Parents About Newborn Screening and Residual Dried Blood Spots: A Randomized Clinical Trial.
    Botkin JR; Rothwell E; Anderson RA; Rose NC; Dolan SM; Kuppermann M; Stark LA; Goldenberg A; Wong B
    JAMA Pediatr; 2016 Jun; 170(6):543-9. PubMed ID: 27043416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening.
    Therrell BL; Hannon WH; Bailey DB; Goldman EB; Monaco J; Norgaard-Pedersen B; Terry SF; Johnson A; Howell RR
    Genet Med; 2011 Jul; 13(7):621-4. PubMed ID: 21602691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.